| Date Filed | Type | Description |
| 05/19/2023 |
4
| POPS RICHARD F (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 4,199 restricted stock units
@ $0 |
|
| 02/24/2023 |
4
| POPS RICHARD F (Director and CEO, Alkermes plc) has filed a Form 4 on Alkermes plc.|
Txns:
| Granted 284,873 options to buy
@ $27.36, valued at
$7.8M
|
|
| 02/22/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2022 |
4
| POPS RICHARD F (Director and CEO, Alkermes plc) has filed a Form 4 on Alkermes plc.|
Txns:
| Sold 221,222 shares
@ $27.9504, valued at
$6.2M
Sold 32,288 shares
@ $28.5935, valued at
$923.2k
Sold 93,747 shares
@ $27.8549, valued at
$2.6M
Exercised 329,153 options to buy
@ $16.55, valued at
$5.4M
Exercised 120,847 options to buy
@ $16.55, valued at
$2M
|
|
| 02/23/2022 |
4
| POPS RICHARD F (Director and CEO, Alkermes plc) has filed a Form 4 on Alkermes plc.|
Txns:
| Paid exercise price by delivering 14,386 shares
@ $25.08, valued at
$360.8k
Granted 299,044 options to buy
@ $25.08, valued at
$7.5M
Exercised 32,400 options to buy
@ $0 |
|
| 02/17/2022 |
4
| POPS RICHARD F (Director and CEO, Alkermes plc) has filed a Form 4 on Alkermes plc.|
Txns:
| Paid exercise price by delivering 8,038 shares
@ $26.79, valued at
$215.3k
Exercised 18,125 options to buy
@ $0 |
|
| 09/16/2021 |
4
| POPS RICHARD F (Director and CEO, Alkermes plc) has filed a Form 4 on Alkermes plc.|
Txns:
| Granted 81,682 shares
@ $0
Paid exercise price by delivering 36,267 shares
@ $30.6, valued at
$1.1M
|
|
| 05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| POPS RICHARD F (Director and CEO, Alkermes plc) has filed a Form 4 on Alkermes plc.|
Txns:
| Paid exercise price by delivering 8,074 shares
@ $19.79, valued at
$159.8k
Paid exercise price by delivering 3,869 shares
@ $19.97, valued at
$77.3k
Exercised 18,125 options to buy
@ $0
Exercised 8,750 options to buy
@ $0 |
|
| 06/02/2020 |
4
| POPS RICHARD F (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 14,013 options to buy
@ $17.55, valued at
$245.9k
|
|
| 05/21/2020 |
4
| POPS RICHARD F (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 6,018 options to buy
@ $119.93, valued at
$721.7k
|
|
| 05/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2020 |
4
| POPS RICHARD F (Director and CEO, Alkermes plc) has filed a Form 4 on Alkermes plc.|
Txns:
| Sold 50,000 shares
@ $13.79, valued at
$689.5k
Exercised 50,000 options to buy
@ $11.74, valued at
$587k
|
|
| 03/26/2020 |
4
| POPS RICHARD F (Director and CEO, Alkermes plc) has filed a Form 4 on Alkermes plc.|
Txns:
| Sold 75,000 shares
@ $14.363, valued at
$1.1M
Exercised 75,000 options to buy
@ $11.74, valued at
$880.5k
|
|
| 03/19/2020 |
4
| POPS RICHARD F (Director and CEO, Alkermes plc) has filed a Form 4 on Alkermes plc.|
Txns:
| Sold 10,346 shares
@ $13.4223, valued at
$138.9k
Sold 48,668 shares
@ $14.5099, valued at
$706.2k
Sold 15,986 shares
@ $15.0377, valued at
$240.4k
Exercised 75,000 options to buy
@ $11.74, valued at
$880.5k
|
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/08/2019 |
4
| POPS RICHARD F (Director and CEO, Alkermes plc) has filed a Form 4 on Alkermes plc.|
Txns:
| Sold 69,795 shares
@ $19.8097, valued at
$1.4M
Sold 30,205 shares
@ $19.7261, valued at
$595.8k
Exercised 69,795 options to buy
@ $9.21, valued at
$642.8k
Exercised 30,205 options to buy
@ $9.21, valued at
$278.2k
|
|
| 09/23/2019 |
4
| POPS RICHARD F (Director and CEO, Alkermes plc) has filed a Form 4 on Alkermes plc.|
Txns:
| Sold 100,000 shares
@ $21.5355, valued at
$2.2M
Exercised 100,000 options to buy
@ $9.21, valued at
$921k
|
|
| 09/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2019 |
4
| POPS RICHARD F (Director and CEO, Alkermes plc) has filed a Form 4 on Alkermes plc.|
Txns:
| Sold 100,000 shares
@ $20.1783, valued at
$2M
Exercised 100,000 options to buy
@ $9.21, valued at
$921k
|
|
| 06/07/2019 |
4
| POPS RICHARD F (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 17,633 options to buy
@ $13.74, valued at
$242.3k
|
|
| 05/24/2019 |
4
| POPS RICHARD F (Director and CEO, Alkermes plc) has filed a Form 4 on Alkermes plc.|
Txns:
| Sold 60,000 shares
@ $25.4213, valued at
$1.5M
Sold 50,000 shares
@ $24.223, valued at
$1.2M
Exercised 60,000 options to buy
@ $8.55, valued at
$513k
Exercised 50,000 options to buy
@ $8.55, valued at
$427.5k
|
|
|